Alife
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Features Embryo Predict, the first commercially available FDA-cleared AI tool for embryo assessment in IVF in the U.S., supported by multi-center randomized clinical trials and peer-reviewed research.
Description Brand's website · 2026-10-04
Alife is a company developing AI-powered software and technology for In Vitro Fertilization (IVF) to assist clinics and patients in improving outcomes and operational efficiencies. Their platform includes tools for embryo assessment, clinic scheduling, and patient conversion.
Offerings
Core capabilities Brand's website · 2026-10-04
- AI-powered software platform for IVF clinics
- including Embryo Predict (AI embryo assessment)
- Schedule Predict (clinic efficiency)
- Success Predictor (patient conversion)
- Alife Assist™ configurable platform
- Alife App for patients
- and an IVF Calculator.
Audience
Target industry Brand's website · 2026-10-04
IVF clinics, fertility leaders, embryologists, reproductive endocrinologists, and patients undergoing fertility treatment in the U.S. and Europe.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Alife's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Alife across the index.
Claim Alife — free →Page last updated 2026-10-17.